The Biotechnology Business Institute and Richi Foundation join forces to boost business development in childhood cancer research

Paula Cañal
Jun 5, 2018


As part of its commitment with innovation and entrepreneurship, the Biotechnology Business Institute and Richi Entrepreneurs present the first Childhood Cancer Innovation Award, a charity event in favor of pediatric investigation.

The Summer Charity Cocktail will take place next June 29th, in an unique spot of the coast of Barcelona, which will gather together family, friends, colleagues and professionals of the biopharmaceutical sector to discover the winner between the three projects preselected by an expert jury. The winner company will have the opportunity to travel and meet the city of Boston, owner of one of the most promising innovation hubs in Life Sciences of the world.

The founder of Richi Foundation, Ricard García, currently living in the United States, has expressed his support to the Summer Charity Cocktail and will be present during the event, where García will be part of the expert jury. The candidatures of the three finalist startups from the biotechnology area, Iproteos, BIOGENERA SpA and Parpipred (VHIO), will be valued by an expert jury that will evaluate the innovative nature of the projects and the potential impact in the run against pediatric cancer.

Richi Entrepreneurs, the immersion program of Richi Cildhood Cancer Foundation, is an initiative whose mission is to boost startups from all over the world that have the potential to generate a positive impact on society in the health space, by connecting them with Boston’s innovation key players -industry, investors, hospitals, accelerators, academia and other potential partners- and helping them make the most out of this unique innovation ecosystem.

“The agreement with Richi Foundation is part of one of the main objectives of the Institute. From the academic programs, the Biotechnology Business Institute promotes entrepreneurship and the development of innovative ideas in the biotechnology and biomedicine areas, as well as future leaders in Pharmaceutical and Biotechnology sector”, has expressed Juan R. García, Managing Partner of the Institute.

The award ceremony of the Childhood Cancer Innovation Award is celebrated together with the 5th anniversary of the Biotechnology Business Institute. The business school reaches five years of continuous education of professionals and future leaders of the biotechnology and pharmaceutical sector.

“This event is a great example of how to leverage a special occasion - the 5th anniversary of IEB - to give back to society”, has explained Ernest Lara, Executive Director of Richi Entrepreneurs. “We truly thank the Biotechnology Business Institute for giving us the opportunity of connecting our activity at Richi Entrepreneurs with the original mission of the Richi Childhood Cancer Foundation, by supporting the startup with the highest potential for impact in childhood cancer”. 

Latest news

The Biotechnology Business Institute signs a strategic collaboration agreement with IRB Barcelona, the Fundació Bosch i Gimpera and UPF, promoted by UPF Ventures, in a new educational model for drug discovery and technology transfer

The Biotechnology Business Institute (BBI) incorporates Discover & Transfer to the programs, where the students will be working with real drug candidates of these three institutions.

BIOSPAIN 2018 consolidates the congress as the 5th world biotechnology event

The ninth edition of the BIOSPAIN International Biotechnology Meeting, which ASEBIO organizes every two years, brought together more than 600 companies from 30 countries in the city of Seville.

The Summer Charity Cocktail supports companies researching in pediatric cancer, under the first Childhood Cancer Innovation Award

The charity event, organized by the Biotechnology Business Institute in collaboration with the Richi Childhood Cancer Foundation, raised money from the attendees to boost innovative companies researching in pediatric oncology.

El IEB firma acuerdos de colaboración con el IRB y la Fundació Bosch i Gimpera para su nueva actividad, Discover and Transfer

El IRB Barcelona y la Fundació Bosch i Gimpera se suman a los programas formativos de máster y posgrado del Instituto Empresarial de Biotecnología con la firma de convenios de colaboración en el marco de la actividad Discover and Transfer. Esta alianza permite a los estudiantes del actual año académico el seguimiento de 4 patentes – dos de cada centro – de forma paralela a las clases teóricas.

Filter by category